Adastra Holdings Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Adastra Holdings.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth58.2%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Adastra Holdings Ltd.'s (CSE:XTRX) Shares Leap 26% Yet They're Still Not Telling The Full Story

Mar 08
Adastra Holdings Ltd.'s (CSE:XTRX) Shares Leap 26% Yet They're Still Not Telling The Full Story

Adastra Holdings Ltd.'s (CSE:XTRX) Shares Not Telling The Full Story

Jan 23
Adastra Holdings Ltd.'s (CSE:XTRX) Shares Not Telling The Full Story

Here's Why Adastra Holdings (CSE:XTRX) Can Afford Some Debt

Sep 28
Here's Why Adastra Holdings (CSE:XTRX) Can Afford Some Debt

Subdued Growth No Barrier To Adastra Holdings Ltd.'s (CSE:XTRX) Price

Aug 03
Subdued Growth No Barrier To Adastra Holdings Ltd.'s (CSE:XTRX) Price

Does Adastra Holdings (CSE:XTRX) Have A Healthy Balance Sheet?

Jan 13
Does Adastra Holdings (CSE:XTRX) Have A Healthy Balance Sheet?

We Think Adastra Holdings (CSE:XTRX) Has A Fair Chunk Of Debt

Sep 28
We Think Adastra Holdings (CSE:XTRX) Has A Fair Chunk Of Debt

Does Adastra Holdings (CSE:XTRX) Have A Healthy Balance Sheet?

Mar 23
Does Adastra Holdings (CSE:XTRX) Have A Healthy Balance Sheet?

Here's Why Adastra Holdings (CSE:XTRX) Can Afford Some Debt

Dec 07
Here's Why Adastra Holdings (CSE:XTRX) Can Afford Some Debt

Here's Why Phyto Extractions (CSE:XTRX) Can Afford Some Debt

Aug 18
Here's Why Phyto Extractions (CSE:XTRX) Can Afford Some Debt

Auditors Have Doubts About Phyto Extractions (CSE:XTRX)

May 04
Auditors Have Doubts About Phyto Extractions (CSE:XTRX)

Adastra Labs Holdings (CSE:XTRX) Is Making Moderate Use Of Debt

Dec 10
Adastra Labs Holdings (CSE:XTRX) Is Making Moderate Use Of Debt

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Adastra Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

CNSX:XTRX - Analysts future estimates and past financials data (CAD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/202321-523N/A
6/30/202321-523N/A
3/31/202317-423N/A
12/31/202213-411N/A
9/30/202211-3-10N/A
6/30/20229-3-1-1N/A
3/31/20227-3-1-1N/A
12/31/20216-3-2-1N/A
9/30/20215-1-2-1N/A
6/30/20214-5-4-2N/A
3/31/20213-5-4-3N/A
12/31/20202-8-5-3N/A
9/30/20201-11-5-4N/A
6/30/20200-7-6-4N/A
3/31/2020N/A-7-9-2N/A
12/31/2019N/A-4-9-2N/A
10/31/2019N/A-2-9-1N/A
7/31/2019N/A-1-7-1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if XTRX's forecast earnings growth is above the savings rate (2%).

Earnings vs Market: Insufficient data to determine if XTRX's earnings are forecast to grow faster than the Canadian market

High Growth Earnings: Insufficient data to determine if XTRX's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if XTRX's revenue is forecast to grow faster than the Canadian market.

High Growth Revenue: Insufficient data to determine if XTRX's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if XTRX's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.